- info@myglp1store.com
- +1 (904) 942-2327
- 6953 Powers avenue suite 19 Jacksonville Fl 32217
Need Any Help?
+1 (904) 942-2327
+1 (904) 942-2327
Price range: $75.00 through $720.00
Tirzepatide is an investigational synthetic peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 and GIP receptor signaling pathways. This compound is intended strictly for experimental research use only and is not approved for human or veterinary applications.
Ingredients / Composition:
| Component | Description |
|---|---|
| Active Compound | Tirzepatide (synthetic dual-agonist peptide for GLP-1 and GIP receptors) |
| Net Peptide Content | 5 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry |
Tirzepatide is referenced in scientific literature for studies examining receptor binding kinetics, intracellular signaling activation, and metabolic pathway modulation. All references are provided strictly for scientific context and experimental design and are not intended as dosing or usage guidance.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Tirzepatide is a dual-agonist peptide designed for laboratory research into GLP-1 and GIP receptor signaling pathways. Its molecular structure allows researchers to study ligand-receptor interactions, intracellular signal transduction, and metabolic pathway dynamics in controlled experimental systems.
Tirzepatide may be utilized in experimental studies including:
GLP-1 and GIP receptor binding affinity and kinetics
Intracellular signaling pathway analysis
Secondary messenger and gene expression response evaluation
Comparative dual-agonist peptide structureāactivity research
Stability, degradation, and formulation studies
These studies support mechanistic investigations into dual-incretin receptor function and related cellular signaling networks.
Store under laboratory-appropriate cold conditions to maintain peptide stability. Handle using standard laboratory peptide protocols. Reconstitution, aliquoting, and storage should follow institutional guidelines.
This product is provided strictly for laboratory and scientific research use. Not intended for:
Human consumption
Animal use
Diagnostic procedures
Therapeutic or clinical applications
No physiological, medical, or performance outcomes are implied or guaranteed. Researchers are responsible for institutional and regulatory compliance when handling investigational compounds.
Tirzepatide is an investigational synthetic peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 and GIP receptor signaling pathways. This compound is intended strictly for experimental research use only and is not approved for human or veterinary applications.
Ingredients / Composition:
| Component | Description |
|---|---|
| Active Compound | Tirzepatide (synthetic dual-agonist peptide for GLP-1 and GIP receptors) |
| Net Peptide Content | 5 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry |
Tirzepatide is referenced in scientific literature for studies examining receptor binding kinetics, intracellular signaling activation, and metabolic pathway modulation. All references are provided strictly for scientific context and experimental design and are not intended as dosing or usage guidance.
Reviews
There are no reviews yet.